Education
About Us
Working with TipRanks
Follow Us
Omnicell (OMCL)
NASDAQ:OMCL
OMCL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$22.66 - $55.75
Previous CloseN/A
Volume97.52K
Average Volume (3M)496.32K
Market Cap
$1.43B
Enterprise Value$1.33B
Total Cash (Recent Filing)$399.00M
Total Debt (Recent Filing)$372.56M
Price to Earnings (P/E)63.0
Beta0.30
Next Earnings
Nov 04, 2025EPS Estimate
0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.45
Shares Outstanding46,843,605
10 Day Avg. Volume622,306
30 Day Avg. Volume496,316
Financial Highlights & Ratios
PEG Ratio-1.02
Price to Book (P/B)1.65
Price to Sales (P/S)1.84
P/FCF Ratio13.55
Enterprise Value/Market Cap0.93
Enterprise Value/Revenue1.16
Enterprise Value/Gross Profit2.65
Enterprise Value/Ebitda14.23
Forecast
1Y Price Target
$42.67Price Target Upside37.51% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Bulls Say, Bears Say
Bulls Say
EarningsThe company achieved higher-than-expected revenue and adjusted EBITDA, surpassing guidance and consensus estimates.
Revenue GuidanceOmnicell continues to execute well, as management reaffirmed this year’s bookings and revenue guidance.
TariffsA potential post-pause tariff rate of 55% implies a favorable scenario for Omnicell, leading to significant savings.
Bears Say
CapEx OutlookThe broader CapEx outlook weakened for the second consecutive quarter as uncertainty around tariffs and legislation appear to be impacting spend.
Tariff VolatilityThe ever-changing tariff backdrop, particularly with China, has led to two guidance revisions and significant stock price volatility.
Omnicell News
OMCL FAQ
What was Omnicell’s price range in the past 12 months?
Omnicell lowest stock price was $22.66 and its highest was $55.74 in the past 12 months.
What is Omnicell’s market cap?
Omnicell’s market cap is $1.43B.
When is Omnicell’s upcoming earnings report date?
Omnicell’s upcoming earnings report date is Nov 04, 2025 which is in 88 days.
How were Omnicell’s earnings last quarter?
Omnicell released its earnings results on Jul 31, 2025. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.18.
Is Omnicell overvalued?
According to Wall Street analysts Omnicell’s price is currently Undervalued.
Does Omnicell pay dividends?
Omnicell does not currently pay dividends.
What is Omnicell’s EPS estimate?
Omnicell’s EPS estimate is 0.37.
How many shares outstanding does Omnicell have?
Omnicell has 46,843,605 shares outstanding.
What happened to Omnicell’s price movement after its last earnings report?
Omnicell reported an EPS of $0.45 in its last earnings report, beating expectations of $0.27. Following the earnings report the stock price went up 4.411%.
Which hedge fund is a major shareholder of Omnicell?
Currently, no hedge funds are holding shares in OMCL
Omnicell Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$42.67 (37.51% Upside)
$42.67 (37.51% Upside)
Blogger Sentiment
Bullish
OMCL Sentiment 66%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 157.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.1%
Last 30 Days ▼ 2.0%
Last 30 Days ▼ 2.0%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.81%
12-Months-Change
Fundamentals
Return on Equity
1.87%
Trailing 12-Months
Asset Growth
-6.38%
Trailing 12-Months
Company Description
Omnicell
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
OMCL Company Deck
OMCL Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong financial performance with notable revenue growth and strategic product launches, despite challenges from tariffs and a decrease in non-GAAP earnings per share. The company's ability to reaffirm and modestly increase guidance for the full year suggests confidence in overcoming headwinds.View all OMCL earnings summariesOMCL Stock 12 Month Forecast
Average Price Target
$42.67
▲(37.51% Upside)
Technical Analysis
Ownership Overview
2.90% Insiders
31.00% Mutual Funds
0.16% Other Institutional Investors
33.14% Public Companies and
Individual Investors